Navigation Links
DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
Date:7/27/2009

CUPERTINO, Calif., July 27 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2009 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Monday, August 3, 2009 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(R), POSIDUR(TM), ELADUR(TM), and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(R), TRANSDUR(TM), and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
2. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
3. DURECT to Participate in Cowen and Company Healthcare Conference
4. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
5. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
6. DURECT Corporation to Participate in Upcoming Healthcare Conferences
7. DURECT Corporation to Participate in Upcoming Healthcare Conferences
8. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
9. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
10. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
11. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... What: Shriners Hospitals for Children, with the help of Dimension ... using a video monitor and web-enabled camera. Santa visits with children through Dimension Data’s ... Christmas Wonderland, which is where the video connection to the North Pole will stream. ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a tool ... effect without heavy rendering or complicated compositing," said Christina Austin - CEO of Pixel ... an organic spectrum of lights that simulates the look of a glare. Just ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Surgery, is excited to announce the arrival of the newest Sciton laser in ... the ability to use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming ...
(Date:12/5/2016)... ... December 05, 2016 , ... The Avamere Family of Companies ... Avamere Transitional Care of Puget Sound ; located at 630 S Pearl Street, ... provide patients recovering from illness or injury with intensive skilled nursing and rehabilitation ...
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 ... the Lithuanian language and its poetry inspired him in writing “ Forest ... all aspects of a living, breathing forest where nothing ever stays the same. His ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  Balloon catheter is ... which is inserted into the femoral artery in the ... arm to treat constricted blood vessels. These products are ... to atherosclerosis – deposition of lipid substances in the ... catheter market is projected to expand at a CAGR ...
(Date:12/5/2016)... , Dec. 5, 2016  Zimmer Biomet Holdings, Inc. ... that, pursuant to its previously-announced cash tender offers ... the table below (collectively, the "Notes"), approximately $2.6 billion ... tendered and not validly withdrawn on or prior ... time, today, December 5, 2016 (the "Early ...
(Date:12/5/2016)... LONDON , Dec. 5 2016 ... 2022 Summary GlobalData,s new report, "United ... provides key market data on the United Kingdom ... in millions of US dollars, volume (in units) ... Optical Coherence Tomography (OCT), Retinal Ultrasound Imaging Systems, ...
Breaking Medicine Technology: